BidaskClub Upgrades LivaNova (LIVN) to Buy
BidaskClub upgraded shares of LivaNova (NASDAQ:LIVN) from a hold rating to a buy rating in a research note published on Wednesday.
A number of other research firms also recently weighed in on LIVN. Zacks Investment Research downgraded LivaNova from a hold rating to a strong sell rating in a research report on Thursday, January 25th. ValuEngine upgraded LivaNova from a hold rating to a buy rating in a research report on Friday, February 2nd. Needham & Company LLC raised their price target on LivaNova to $93.00 and gave the company a buy rating in a research report on Tuesday, November 21st. Canaccord Genuity restated a hold rating and set a $76.00 price target on shares of LivaNova in a research report on Tuesday, December 5th. Finally, Piper Jaffray Companies restated a buy rating and set a $85.00 price target on shares of LivaNova in a research report on Friday, November 3rd. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the stock. LivaNova currently has an average rating of Hold and a consensus target price of $79.71.
Shares of LivaNova (LIVN) opened at $87.87 on Wednesday. LivaNova has a 12-month low of $46.34 and a 12-month high of $88.56. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.42 and a current ratio of 2.03. The firm has a market capitalization of $4,141.85, a PE ratio of 75.10, a price-to-earnings-growth ratio of 2.55 and a beta of 0.83.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Rehmann Capital Advisory Group purchased a new position in shares of LivaNova in the fourth quarter worth about $216,000. Segall Bryant & Hamill LLC purchased a new position in shares of LivaNova in the fourth quarter worth about $291,000. Castleark Management LLC purchased a new position in shares of LivaNova in the fourth quarter worth about $8,304,000. Macquarie Group Ltd. increased its holdings in shares of LivaNova by 100.0% in the fourth quarter. Macquarie Group Ltd. now owns 2,800 shares of the company’s stock worth $224,000 after buying an additional 1,400 shares during the period. Finally, Zeke Capital Advisors LLC purchased a new position in shares of LivaNova in the fourth quarter worth about $241,000. Hedge funds and other institutional investors own 87.06% of the company’s stock.
WARNING: “BidaskClub Upgrades LivaNova (LIVN) to Buy” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.thecerbatgem.com/2018/02/24/bidaskclub-upgrades-livanova-livn-to-buy.html.
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.